1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78. PMID:
11857671
2. Apostolidis A, Kirana PS, Chiu G, Link C, Tsiouprou M, Hatzichristou D. Gender and age differences in the perception of bother and health care seeking for lower urinary tract symptoms: results from the hospitalised and outpatients’ profile and expectations study. Eur Urol 2009;56:937-47. PMID:
19683857
3. Lee SW, Doo SW, Yang WJ, Song YS. Importance of relieving the most bothersome symptom for improving quality of life in male patients with lower urinary tract symptoms. Urology 2012;80:684-7. PMID:
22770617
4. Majima T, Yamamoto T, Funahashi Y, Takai S, Matsukawa Y, Yoshida M, et al. Effect of naftopidil on bladder microcirculation in a rat model of bladder outlet obstruction. Low Urin Tract Symptoms 2017;9:111-6. PMID:
28394495
6. Sugaya K, Miyazato T, Koyama Y, Hatano T, Ogawa Y. Pelvic congestion syndrome caused by inferior vena cava reflux. Int J Urol 2000;7:157-9. PMID:
10810974
7. Sugaya K, Nishijima S, Kadekawa K, Noguchi K, Ashitomi K, Ueda T, et al. Pelvic venous congestion induces lower urinary tract dysfunction in rats. Biomed Res 2018;39:269-77. PMID:
30531156
8. Ismaeel A, Brumberg RS, Kirk JS, Papoutsi E, Farmer PJ, Bohannon WT, et al. Oxidative stress and arterial dysfunction in peripheral artery disease. Antioxidants (Basel) 2018 Oct 19;7(10):pii: E145.
https://doi.org/10.3390/antiox7100145.
9. Gotoh M, Kamihira O, Kinukawa T, Ono Y, Ohshima S, Origasa H, et al. Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial. BJU Int 2005;96:581-6. PMID:
16104914
10. Takei R, Ikegaki I, Shibata K, Tsujimoto G, Asano T. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol 1999;79:447-54. PMID:
10361884
11. Sugaya K, Nishijima S, Tasaki S, Kadekawa K, Miyazato M, Ogawa Y. Effects of propiverine and naftopidil on the urinary ATP level and bladder activity after bladder stimulation in rats. Neurosci Lett 2007;429:142-6. PMID:
17997223
12. Sugaya K, Nishijima S, Kadekawa K, Ashitomi K, Ueda T, Yamamoto H. Spinal mechanism of micturition reflex inhibition by naftopidil in rats. Life Sci 2014;116:106-11. PMID:
25258114
13. Yokoyama O, Yusup A, Oyama N, Aoki Y, Tanase K, Matsuta Y, et al. Improvement of bladder storage function by alpha1-blocker depends on the suppression of C-fiber afferent activity in rats. Neurourol Urodyn 2006;25:461-7. PMID:
16673377
14. Sugaya K, Nishijima S, Kadekawa K, Ashitomi K, Ueda T, Yamamoto H. Naftopidil improves locomotor activity and urinary frequency in rats with pelvic venous congestion. Biomed Res 2016;37:221-6. PMID:
27544997
15. Sugaya K, de Groat WC. Influence of temperature on activity of the isolated whole bladder preparation of neonatal and adult rats. Am J Physiol Regul Integr Comp Physiol 2000;278:R238-46. PMID:
10644645
16. Mitsui T, Kitazawa T, Ikebe M. Correlation between high temperature dependence of smooth muscle myosin light chain phosphatase activity and muscle relaxation rate. J Biol Chem 1994;269:5842-8. PMID:
8119926
17. Liu X, Zhang X, Huang J, Rong Y, Luo C, Guo J, et al. Enantiospecific determination of naftopidil by RRLC-MS/MS reveals stereoselective pharmacokinetics and tissue distributions in rats. J Pharm Biomed Anal 2015;112:147-54. PMID:
25985066
18. Akino H, Ito H, Nagase K, Matsuta Y, Aoki Y, Hattori T, et al. α1-Blocker inhibits non-voiding contractions and decreases the level of intravesical prostaglandin E2 in rats with partial bladder outlet obstruction. Int J Urol 2019;26:924-30. PMID:
31317581
19. Sakai T, Kasahara K, Tomita K, Ikegaki I, Kuriyama H. Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats. Eur J Pharmacol 2013;700:194-200. PMID:
23274492
21. Nishijima S, Sugaya K, Fukuda T, Miyazato M, Ashimine S, Ogawa Y. Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders. Int J Urol 2006;13:1479-83. PMID:
17118021
22. Andersson KE, Persson K. Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology. Scand J Urol Nephrol Suppl 1995;175:43-53. PMID:
8771275
24. Mitsui T, Kira S, Ihara T, Sawada N, Nakagomi H, Miyamoto T, et al. Metabolomics approach to male lower urinary tract symptoms: identification of possible biomarkers and potential targets for new treatments. J Urol 2018;199:1312-8. PMID:
29175111
25. Pintér E, Szolcsányi J. Plasma extravasation in the skin and pelvic organs evoked by antidromic stimulation of the lumbosacral dorsal roots of the rat. Neuroscience 1995;68:603-14. PMID:
7477970
27. Nishijima S, Sugaya K, Kadekawa K, Ashitomi K, Ueda T, Yamamoto H, et al. High-dose tranilast administration to rats creates interstitial cystitis-like symptoms with increased vascular permeability. Life Sci 2013 26;93:897-903. PMID:
24157455
28. Saito M, Kondo A, Gotoh M, Kato K, Levin RM. Age-related changes in the response of the rat urinary bladder to neurotransmitters. Neurourol Urodyn 1993;12:191-200. PMID:
7920677